type here...

CATEGORIES

Patient Zone

LATEST

1234...59Page 3 of 59

TRENDING

EDITORS CHOICE

First Drug Synthesized by AI Goes into Clinical Trials

Dr Sohail Merchant -
If all goes well, thanks to artificial intelligence, we may soon have a new AI-synthesized drug capable of assisting OCD patients in managing their symptoms and thus leading normal lives.

FBN1 gene, fibrillin 1

Medika Life -
The FBN1 gene provides instructions for making a large protein called fibrillin-1. This protein is transported out of cells into the extracellular matrix, which is an intricate lattice of proteins and other molecules that forms in the spaces between cells.

The Mechanics of Vaping and Its Medical Impact on Your Health

Robert Turner, Founding Editor -
How safe is vaping? What medical literature exists to support claims of safety or the contrary? Medika examines the lucrative industry.

Rethinking Blood Pressure

Michael Hunter, MD -
IS YOUR BLOOD PRESSURE NORMAL? Are you sure? Researchers are moving the bar on what constitutes an “ideal” blood pressure. Today we explore a study suggesting...

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories